- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT00422643
The Effect of Intraaricular Knee Injections of Hyaluronic Acid (HA) on Bone and Cartilaginous Debris, as a Therapeutic Indicator
Osteoarthritis is the most common disease effecting human beings with incidence of about 20% and prevalence close to 80% of the adult population. It is most common after the age of 60 years and more in females with the ratio 4:1 F:M. Osteoarthritis Can be present in every hyaline joint, but is mostly damaging to the weight bearing joints, the knees and hips. At the final stage of cartilage destruction (from wear and tear) joint replacement is the solution. Since these operations were introduced about 50 years ago, the indications and the number of yearly procedures has been increasing with alarming speed. Last year in the united states, about 500,000 Total Knee procedures were done, exceeding Total Hip replacements.
By 2030, close to 4.5 million joint replacement procedures are expected in the United States, the majority of which will be knee replacements. Joint replacement is the solution for the final stage of damaged cartilage. In early and advanced stages of cartilage wear and specifically in the knee H.A. acts as an anti inflammatory and lubricant agent, reducing the knee pain and improving knee motion and function.
The biological effect of H.A. is well documented in clinical studies and less with scientific evidence derived from patients themselves.
Our study proposal briefly is, as follows:
60 patients with evidence of osteoarthritis of the knees will join the study after I.R.B. (Helsinki Committee) approval. All of them will be examined, x-rays will be performed and blood tests will exclude patients with infections or inflammatory disease. A V.A.S. (Visual Analog Score) and SF-36 evaluation form will be completed prior to each intraarticular injection, in addition to a complete medical examination. The enrolled patients will receive the usual three intraarticular knee injections of H.A.(Arthrease), but prior to each injection, the joint will be aspirated and the joint fluid will be analyzed for Chondroitin sulfate type I and type II as described further in this project.
Three and six months after the third initial injections, the patients will recalled and joint fluid will be aspirated again, followed by an H.A. injections, if symptomatic.
This study is the only one ever proposed, for evaluating joint debris qualitatively and quantitatively. It will provide clinical information as well as objective data on the preservation of the joint cartilage. Hopefully, this study will provide additional information such as the relationship between the presence of debris and symptomatic vs. asymptomatic patients. It may help in determining how long the injected H.A. has an effect and whether serial and periodical injections are indicated.
Inclusion criteria:
1. patients with the diagnosis of Osteoarhtritis of the knee, graded according to Kellgren as grade 1-4
Exclusion criteria:
- Patients that suffer from acute septic arthritis.
- Patients that treated with coumadin and/or other anti-coagulant drugs
- Patients that show mental or physical conditions, which preclude compliance with study and/or device.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Studietyp
Inskrivning
Fas
- Fas 4
Kontakter och platser
Studiekontakt
- Namn: nahum halperin, prof
- Telefonnummer: 3 972-8-9779432
- E-post: debyroay@012.net.il
Studieorter
-
-
-
Zerifin, Israel, 71700
- Orthopedic
-
Kontakt:
- nahum halperin, prof
- Telefonnummer: 972-8-9779432
- E-post: debyroay@012/net.il
-
Huvudutredare:
- nahum halperin, prof
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion criteria:
- Patients with the diagnosis of Osteoarhtritis of the knee, graded according to Kellgren as grade 1-4
Exclusion criteria:
- Patients that suffer from acute septic arthritis.
- Patients that treated with coumadin and/or other anti-coagulant drugs
- Patients that show mental or physical conditions, which preclude compliance with study and/or device.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Utbildning/Rådgivning/Träning
- Tilldelning: Icke-randomiserad
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vad mäter studien?
Primära resultatmått
Resultatmått |
---|
To provide additional information such as the relationship between the presence of debris and symptomatic vs. asymptomatic patients.
|
Determining how long the injected H.A. has an effect and whether serial and periodical injections are indicated.
|
Samarbetspartners och utredare
Sponsor
Samarbetspartners
Utredare
- Huvudutredare: ronen debi, md, Assaf Harofe Medical Center
Studieavstämningsdatum
Studera stora datum
Studiestart
Avslutad studie
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- DEBICTIL
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Artros i knäet
-
Maxx Orthopedics IncRekryteringBenförlust | Periprotesfrakturer | Infektion | Aseptisk lossning | MCL - Medial Collateral Ligament Rupture of the KneeFörenta staterna
-
Klinik Hirslanden, ZurichAvslutadNon Inferiority of the Quantra DeviceSchweiz
-
IRCCS Policlinico S. DonatoRekryteringAnomalous aortic origin of the coronary artery (AAOCA)Italien
-
Mayo ClinicAnmälan via inbjudanAnatomy of the GSV for Rescue Peripheral IV AccessFörenta staterna
-
Maastricht University Medical CenterWingate Institute of NeurogastroenterologyRekryteringfMRI | Transkutan vagus nervstimulering (tVNS) | Nucleus of the Solitary Tract (NTS)Nederländerna, Storbritannien
-
Technical University of MunichInstitut für Allgemeine Pathologie und Pathologische Anatomie der TU... och andra samarbetspartnersOkändAssociation of Heterotopic Gastric Mucosa of the Cervical Esophagus and Globus SensationsTyskland
-
Hospital Universitario La Pazspanish society of orthopedics and traumatologyAvslutadRotator Cuff Tears of the ShoulderSpanien
-
Xiros LtdHar inte rekryterat ännuRivning av rotatorkuffen | Rotator Cuff Skador | Rotator Cuff Revor | Rotator Cuff Tears of the Shoulder
-
Tel-Aviv Sourasky Medical CenterRekryteringPouchitis | Crhon's Disease Like of the PouchIsrael
-
Johannes Gutenberg University MainzDentsply Sirona ImplantsOkändLutande atrofi av den distala underkäken | Socket Like Atrophy of the Esthetic ZoneTyskland
Kliniska prövningar på Sodium hyaluronate (hyaluronic acid)
-
IBSA Farmaceutici Italia SrlAktiv, inte rekryterande